Novo Nordisk CEO Mike Doustdar Talks Drug Sales
Novo Nordisk has cut its forecast for the fourth time this year, after disappointing sales of its blockbuster drugs Wegovy and Ozempic. It underscores the challenges facing its new chief executive Mike Doustdar. He spoke to Bloomberg's Guy Johnson about the experience so far.
See omnystudio.com/listener for privacy information.
You May Also Like
🇨🇭🇫🇷 Gardez une tendance d'avance sur les marchés avec Swissquote
Thomas Veillet et Vincent Ganne vous proposent un aperçu de toutes les catégories d'actifs
Real Relationships Real Revenue - Audio Edition | Invest in Relationships to Build Your Business and Your Career
Mo Bunnell | CEO and Founder of Bunnell Idea Group | Author of Give to Grow
兆華與股惑仔
李兆華
HOGENT: kwaliteit dus!
The Podcast Planet
Stock Movers
iHeartPodcasts
Aspire with Emma Grede
Emma Grede | Audacy
Wholesaling Inc with Brent Daniels
Find distressed properties for pennies on the dollar and turn them for huge profits!
The Indicator from Planet Money
NPR
Your Money Minute
CNBC
TraDetector Cafè - Educazione Finanziaria
TraDetector Media
🇨🇭🇫🇷 Gardez une tendance d'avance sur les marchés avec Swissquote
Thomas Veillet et Vincent Ganne vous proposent un aperçu de toutes les catégories d'actifs
Real Relationships Real Revenue - Audio Edition | Invest in Relationships to Build Your Business and Your Career
Mo Bunnell | CEO and Founder of Bunnell Idea Group | Author of Give to Grow
兆華與股惑仔
李兆華
HOGENT: kwaliteit dus!
The Podcast Planet
Stock Movers
iHeartPodcasts
Aspire with Emma Grede
Emma Grede | Audacy
Wholesaling Inc with Brent Daniels
Find distressed properties for pennies on the dollar and turn them for huge profits!
The Indicator from Planet Money
NPR
Your Money Minute
CNBC
TraDetector Cafè - Educazione Finanziaria
TraDetector Media
Community discussion